Dual diagnosis;Patología dual: Situación actual y retos de futuro

Adicciones

Volumn 20, Issue 4, 2008, Pages 315-319

  Torrens Mèlich, Marta ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Addiction; Dual diagnosis; Psychiatric co occurrence; Psychiatric comorbidity; Substance use disorder

Indexed keywords

COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; HUMAN; MENTAL DISEASE; REVIEW; SUBSTANCE ABUSE; ADDICTION; EDITORIAL; FORECASTING; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY;

COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FORECASTING; HUMANS; MENTAL DISORDERS; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 58149260317     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.255     Document Type: Review

References (26)

1. Martin-Santos R, Fonseca F, Domingo-Salvany A, Ginés JM, Imaz ML, Navinés R, et al. Dual diagnosis in the psychiatric emergency room in Spain. European J Psychiatry 2006; 20:147-156.
2. Aharonovich E, Liu X, Nunes E, Hasin DS. Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am J Psychiatry 2002; 159:1600-1602.
3. King VL, Kidorf MS, Stoller KB, Brooner RK. Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. J Addict Dis 2000; 19: 65-83.
4. Carey MP, Carey KB, Maisto SA, Gordon CM, Vanable PA. Prevalence and correlates of sexual activity and HIV-related risk behaviour among psychiatric outpatients. J Consult Clin Psychol 2001; 69: 846-850.
5. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91: 31-37.
6. Caton CL, Shrout PE, Eagle PF, Opler LA, Felix A, Dominguez B. Risk factors for homelessness among schizophrenic men: a case-control study. Am J Public Health 1994; 84: 265-270.
7. Vazquez C, Munoz M, Sanz J. Lifetime and 12-month prevalence of DSM-III-R mental disorders among the homeless in Madrid: a European study using the CIDI. Acta Psychiatr Scand 1997; 95: 523-530.
8. Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees: implications for public policy. Am Psyhologist. 1991; 4: 1036-1045.
9. Cuffel B, Shumway M, Chouljian T. A longitudinal study of substance use and community violence in schizophrenia. J Nerv Mental Dis, 1994; 182: 704-708.
10. Flynn PK, Brown BS. Co-occurring disorders in substance abuse treatments: Issues and prospects. J Subst Abuse Treat 2008; 34: 36-47
11. Rodriguez-Llena MC, Domingo-Salvany A, Brugal MT, Silva TC, Sánchez-Nubió A, Torrens M. Psychiatric comorbidity in young heroin users. Drug Alcohol Depend 2006; 84: 48-55.
12. Nocon A, Bergé D, Astals M, Martín-Santos R, Torrens M. Dual diagnosis in an inpatient drug-abuse detoxification unit. Eur Addict Res 2007; 13:192-200.
13. Herrero MJ, Domingo-Salvany A, Torrens M, Brugal MT; ITINERE Investigators. Psychiatric comorbidity in young cocaine users: induced versus independent disorders. Addiction. 2008; 103:284-93.
14. Casas M, Gual A. Patología psiquiátrica asociada al alcoholismo. Adicciones 2002; 14 (Supl 1): 195-219.
15. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57-63.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed -TR. Washington, DC: American Psychiatric Press, 2000.
17. Organización Mundial de la Salud. Décima Revisión de la Clasificación Internacional de las Enfermedades. Trastornos mentales del comportamiento y desarrollo. Descripciones clínicas y pautas para el diagnóstico. Madrid: Meditor, 1992.
18. Torrens M, Martin-Santos R, Samet S. Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotox Res 2006;10:253-61.
19. Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R. Diagnosing Psychiatric Comorbidity in Substance Abusers. Validity of the Spanish Versions of Psychiatric Research Interview for Substance and Mental Disorders (PRISM-IV) and the Structured Clinical Interview for DSM-IV (SCID-IV). Am J Psychiatry. 2004; 161: 1231-1237.
20. Hasin DS, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006; 163: 689-96.
21. Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 2005; 162:1483-93.
22. Saunder JB, Schuckit MA, Sirovatka PJ, Regier Da (Eds.). Diagnostic issues in substance use disorders. Refining the research agenda fro DSM-V. Arlington,: American Psychiatric Press, 2007.
23. Mateu G, Astals M, Torrens M. Comorbilidad psiquiátrica y trastorno por dependencia de opiáceos: del diagnóstico al tratamiento. Adicciones 2005; 17 (Supl 2): 111-121.
24. Green AI, Noordsy DL, Brunette MF, O'Keefe C. Substance abuse and schizophrenia: Pharmacotherapeutic intervention. J Subst Abuse Treat 2008; 34: 61-71.
25. Drake RE, O'Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008; 34: 123-128.
26. Drake RE, Wallach MA, McGovern MP. Future directions in preventing relapse to substance abuse among clients with severe mental illness. Psychiatric Services, 2005; 56: 1297-1302.